Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × COVID-19 × Immunoglobulin G × Clear all

Sponsor

Conditions

Ovarian Neoplasms 14 Fallopian Tube Neoplasms 14 Glioblastoma 7 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Brenner Tumor 6 Squamous Cell Carcinoma of Head and Neck 5 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Melanoma 4 Gliosarcoma 4 Breast Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Recurrent Squamous Cell Lung Carcinoma 3 Oligodendroglioma 3 Urinary Bladder Neoplasms 2 Spinal Cord Neoplasms 2 Medulloblastoma 2 Glioma 2 Colonic Neoplasms 2 Carcinoma 2 Astrocytoma 2 Adenocarcinoma of Lung 2 Vipoma 1 Uveal Melanoma 1 Uterine Neoplasms 1 Urethral Neoplasms 1

Interventions

tocilizumab 1 sotrovimab 1 proxalutamide 1 bemcentinib 1 Therapeutics 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Radiotherapy 1 Janus Kinase Inhibitors 1 Influenza Vaccines 1 Hydroxychloroquine 1 HuMax-IL8 1 Gelsolin 1 Diagnostic Tests, Routine 1 Decision Support Techniques 1 COVID-19 Vaccines 1 Blood Specimen Collection 1 BNT162 Vaccine 1 2019-nCoV Vaccine mRNA-1273 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡